Does Bupropion Increase Heart Rate?

Yes, Bupropion can raise heart rate. Explore the mechanism (NDRI), prevalence of tachycardia, and crucial medical steps for monitoring cardiovascular health.

Bupropion can increase heart rate, but at standard therapeutic doses the bump is typically small, on the order of a few extra beats per minute compared to placebo. That modest average hides real variability from person to person, and the picture shifts considerably in overdose, during intense exercise in the heat, and for people with certain pre-existing conditions. The drug’s stimulant-like pharmacology makes the heart rate question worth understanding in detail.

Why Bupropion Affects Heart Rate at All

Bupropion works by blocking the reuptake of two neurotransmitters: norepinephrine and dopamine. It has no meaningful effect on serotonin, which sets it apart from most other common antidepressants. The norepinephrine piece is the one that matters most for your heart. Norepinephrine is the same chemical your sympathetic nervous system uses to speed up your heart, constrict blood vessels, and prepare your body for action. By keeping more norepinephrine active around nerve terminals, bupropion nudges the cardiovascular system in a mildly stimulant direction.

Research on isolated human heart tissue has shown that bupropion triggers catecholamine release in the heart muscle itself, producing a stronger contraction force. This indirect sympathomimetic activity helps explain why the drug can raise heart rate and blood pressure in some people, even though it is not directly binding to the receptors on the heart that adrenaline targets. Instead, it is coaxing the body’s own adrenaline-like chemicals to stick around longer and do more work.

How Much Heart Rate Changes at Normal Doses

In a double-blind, placebo-controlled trial of people with mild untreated high blood pressure, sustained-release bupropion at 400 mg per day raised the average heart rate by about 2.3 beats per minute, compared to a slight dip in the placebo group. The difference of roughly 3 beats per minute was statistically significant, but for most people that kind of change is barely perceptible. Keep in mind that 400 mg per day is the maximum recommended dose. At 150 mg or 300 mg, the effect is likely smaller, though few trials have zeroed in on heart rate at those lower doses as a primary outcome.

A large randomized trial comparing bupropion, varenicline, and nicotine patches for smoking cessation found only minor changes from baseline in blood pressure and heart rate at 12, 24, and 52 weeks, with no significant differences between the treatment groups. That is reassuring: over the course of a year, bupropion did not create a meaningful heart rate problem compared to a nicotine patch, which itself has sympathomimetic effects.

Still, a subset of people do notice their heart pounding. In a review of therapeutic errors reported to U.S. poison centers (cases where patients accidentally took the wrong dose or took an extra pill), tachycardia or palpitations showed up in about 12 percent of cases. More serious heart rhythm disturbances were not reported in that dataset. A 12 percent rate for an accidental dosing error suggests that under normal, careful use, the proportion of people experiencing palpitations is lower but not negligible.

People With Pre-Existing Heart Disease

Clinicians have historically been cautious about prescribing bupropion to people with cardiovascular problems, mostly because the drug boosts norepinephrine. An older study specifically enrolling depressed patients with heart disease found that bupropion raised supine blood pressure but did not significantly affect pulse rate, did not worsen existing ventricular arrhythmias, and had a low rate of orthostatic hypotension (that dizzy drop in blood pressure when you stand up). That sounds encouraging, but the same study had to discontinue treatment for about 14 percent of participants due to side effects, including a couple of cases where existing high blood pressure got worse.

The takeaway for anyone with a heart condition is mixed. Bupropion looks relatively safe in terms of rhythm disturbances and does not seem to push heart rate up in the way a pure stimulant would. But it does tend to push blood pressure up in a subset of people, and blood pressure and heart rate are closely linked. Your cardiologist and prescribing doctor should be talking to each other if you are starting bupropion and already managing heart disease.

The Stress Response Factor

One underappreciated angle is how bupropion changes your cardiovascular response to stress. A study comparing bupropion to paroxetine (an SSRI) in depressed patients found that the bupropion group had larger increases in a measure of blood vessel resistance and larger spikes in norepinephrine when exposed to mental stress tasks. In plain terms, bupropion seemed to make the body’s “fight or flight” reaction more pronounced than usual.

This does not mean bupropion creates a chronic state of alarm. In fact, earlier biochemical research showed that bupropion actually reduced overall norepinephrine turnover in the body while keeping resting norepinephrine levels steady. The picture is that, at rest, bupropion has a relatively quiet cardiovascular footprint. But when you encounter a stressful situation, whether mental or physical, the drug may amplify the heart rate and blood pressure spikes your body would already produce. If you have noticed your heart racing more during stressful moments since starting bupropion, this mechanism could be the reason.

Exercise Performance and Heart Rate in the Heat

An unexpectedly interesting body of research has explored what bupropion does to cyclists exercising in hot environments. In one study, trained cyclists who took bupropion and then did a time trial in 30°C heat finished about 9 percent faster than on placebo, which sounds like a performance boost. But the cost was striking: both core body temperature and heart rate were significantly higher at the end of the trial under bupropion. Heart rate reached roughly 183 beats per minute on bupropion versus 178 on placebo, and core temperature hit 40.0°C compared to 39.7°C.

A follow-up study found that the heart rate increase during hot-weather exercise was dose-dependent, appearing only at the higher dose. In temperate conditions, bupropion did not have the same effect. A broader review of psychiatric medications and exercise performance confirmed that the heart rate effect was most prominent at the tail end of hard efforts in the heat.

What seems to be happening is that bupropion blunts the brain’s normal “slow down, you’re overheating” safety signals. The dopamine and norepinephrine effects essentially allow you to override internal fatigue cues, pushing harder without fully registering how hot and taxed your body is. The performance gain comes at the price of running your heart faster and your core temperature higher than your body would normally allow. For anyone taking bupropion and exercising hard outdoors on hot days, this is worth knowing: you may not feel as overheated as you actually are, and your heart is working harder than it would otherwise.

What Happens in Overdose

The heart rate picture becomes genuinely dangerous in bupropion overdose. A case report of a 19-year-old woman who overdosed on bupropion documented a pulse of 169 beats per minute on arrival to the emergency department, along with high blood pressure and prolonged QT interval on her electrocardiogram. That case was ultimately fatal. While fatal bupropion overdose is uncommon, tachycardia is one of the most consistent early warning signs that an overdose is becoming serious.

A larger study of bupropion overdose cases found that seizures occurred in about 19 percent of cases, with smaller rates of low blood pressure and abnormal heart rhythms. The peak heart rate recorded within the first eight hours after overdose was a strong predictor of who would go on to have bad outcomes. For every additional beat per minute in that early maximum heart rate, the odds of a serious complication rose by about 7 percent. Emergency physicians now use heart rate as one of their triage signals in bupropion ingestion cases: a rapidly climbing heart rate in the first few hours suggests the situation is heading in the wrong direction.

None of this should alarm someone taking bupropion as prescribed. Overdose toxicology is a fundamentally different scenario than therapeutic use. But it does reinforce that bupropion has genuine cardiovascular activity, and that the heart rate effect scales steeply with dose in a way that other antidepressants generally do not.

Drug Interactions and Heart Rate

An interesting wrinkle emerges from studies pairing bupropion with other stimulant drugs. You might expect that combining two stimulant-like substances would push heart rate even higher, but the research shows the opposite. In a controlled study of healthy volunteers, bupropion actually reduced the heart rate spike caused by MDMA (ecstasy). A similar finding appeared with methamphetamine: bupropion significantly reduced the heart rate increases caused by methamphetamine and showed a trend toward reducing blood pressure spikes as well.

The likely explanation is that bupropion occupies the same norepinephrine and dopamine transporters that MDMA and methamphetamine use to dump catecholamines into the synapse. By partially blocking those transporters in advance, bupropion actually limits how much extra norepinephrine the second drug can release. The result is a dampened cardiovascular response, not an amplified one. This research was done in controlled clinical settings and should never be taken as medical advice about combining drugs. But mechanistically, it illustrates that bupropion’s relationship with heart rate is more nuanced than “it’s a stimulant so it always speeds things up.”

Why Individual Responses Vary So Much

Some people notice their heart racing from the first week on bupropion, while others take it for years without any cardiovascular awareness at all. Part of that variability is genetic. Bupropion is broken down in the liver primarily by an enzyme called CYP2B6, and there are well-documented genetic variants of this enzyme that change how quickly you metabolize the drug. People carrying certain gene variants had roughly a third less of one key bupropion metabolite (hydroxybupropion) in their blood, and genotype plus sex together accounted for about half of the variation in that metabolite’s concentration.

This matters because hydroxybupropion is pharmacologically active, potentially even more so than the parent drug. If your genetics lead you to accumulate more of it, you are effectively getting a higher dose of active compound than someone else taking the same pill. That could mean more norepinephrine activity, more sympathetic nervous system stimulation, and a faster heart rate. Pharmacogenomic testing for CYP2B6 is available and sometimes ordered by psychiatrists trying to understand why a patient is unusually sensitive or resistant to bupropion’s effects. It is not yet a routine part of prescribing, but it can be useful when someone experiences outsized side effects at a standard dose.

Beyond genetics, other factors contribute to individual variation. Caffeine intake, other medications that interact with CYP2B6, hydration status, body weight, and baseline anxiety levels all modulate how strongly bupropion’s cardiovascular effects manifest. Anxiety in particular can be a complicating factor, since bupropion occasionally worsens anxiety in the first few weeks, and anxiety itself raises heart rate via the same sympathetic pathway bupropion activates. Sorting out whether a faster pulse is from the medication or from the anxiety it may be worsening is a genuine diagnostic challenge.

How Bupropion Compares to Other Antidepressants

SSRIs like sertraline and escitalopram are generally considered to have a neutral or even mildly heart-rate-lowering effect, making them a common first choice for people with cardiovascular concerns. Tricyclic antidepressants sit at the other end of the spectrum, with well-known risks for arrhythmias and significant heart rate increases. Bupropion falls somewhere in the middle. It is friendlier to the heart than older tricyclics but more cardiovascularly active than most SSRIs.

One practical comparison comes from the smoking cessation trial mentioned earlier, where bupropion, varenicline, and nicotine patches all showed similar, minor cardiovascular profiles over a year. For smoking cessation specifically, where the alternative is often continued smoking (which itself dramatically worsens cardiovascular health), the small heart rate effect of bupropion is a trivial concern relative to the cardiovascular damage done by cigarettes.

There has been some interest in whether naltrexone-bupropion, a combination weight-loss medication, might carry heart risks. A large cardiovascular outcome trial was initiated, but it was terminated early due to low adherence, so no reliable conclusions about long-term cardiovascular safety could be drawn. That gap in the evidence is worth noting for anyone considering long-term use of the combination.

When to Talk to Your Doctor About Heart Rate on Bupropion

A resting heart rate that is consistently running 5 or more beats per minute higher than your pre-medication baseline deserves a conversation with your prescriber. A few beats higher, with no symptoms, is usually something to monitor rather than act on. Palpitations, the sensation of your heart pounding or fluttering, are more common in the first couple of weeks and frequently settle down once your body adjusts to the drug. If palpitations persist beyond a month or are accompanied by dizziness, chest pain, or feeling faint, that warrants a medical evaluation.

People who exercise regularly can use their workout heart rate data as an early warning system. If your heart rate during the same intensity of exercise is climbing week over week after starting bupropion, especially in warm conditions, that is the drug at work. Adjusting exercise intensity on hot days, staying well hydrated, and being willing to stop when you feel off are reasonable precautions. Fitness trackers are imperfect measuring devices but good enough to catch a trend.

For most people, the heart rate effect of bupropion at 150 or 300 mg per day is small enough to be clinically irrelevant. The anxiety-reducing effect of treating depression itself may even offset any small sympathetic stimulation the drug adds. Where clinicians pay closer attention is at the 450 mg ceiling dose, in patients with uncontrolled hypertension, or in people simultaneously taking other drugs that raise norepinephrine. In those cases, periodic blood pressure and heart rate checks are a routine part of follow-up care.